Acutaas Chemicals has reported its financial results for the fourth quarter and fiscal year ended March 31, 2026. The company achieved its highest ever Profit After Tax (PAT) of INR356.4 crores for FY26, with revenue from operations reaching INR1,339.4 crores. Building on this strong performance, the management has expressed confidence in delivering 25% revenue growth in FY27.

Financial Performance for FY26

The company closed the fiscal year with robust financial metrics, reflecting significant year-on-year growth. The Managing Director highlighted that the results demonstrate the strength of their business model and disciplined execution.

Strategic Initiatives and Growth Drivers

Management outlined progress across multiple verticals to support future growth. In the battery chemicals business, the company has commercialized its first two products and expects to bring two additional products to commercial scale in FY27. The semiconductor business, particularly through BFC, is gaining traction with new products expected to contribute meaningfully in the coming year. Additionally, the R&D centre for the South Korea joint venture, Indichem, is operational and has started sending samples to prospective customers.

FY27 Outlook and Guidance

Acutaas Chemicals has guided for 25% revenue growth in FY27. This projection is backed by a strong pipeline across all three verticals: pharmaceutical intermediates, battery chemicals, and semiconductors. The management indicated that while near-term cost pressures from global supply chain disruptions exist, they are confident in maintaining EBITDA margins at levels similar to FY26. The company also noted that its existing infrastructure is well-positioned to support growth through FY28.

Acutaas Chemicals Limited announced robust financial results for the quarter ended March 31, 2026, demonstrating significant growth across key performance metrics. The company reported Q4 net profit of ₹1,343 million compared to ₹627 million in the same period last year, while revenue reached ₹4,328 million versus ₹3,085 million year-on-year, marking substantial growth in both profitability and top-line performance.

Strong Financial Performance in Q4

The company delivered exceptional financial results with profit after tax (PAT) reaching ₹1,343 million, representing a remarkable 114.1% growth compared to the previous year's ₹627 million. The revenue performance was equally impressive, with Q4 revenue of ₹4,328 million showing strong year-on-year growth from ₹3,085 million in the corresponding quarter of the previous year.

EBITDA Performance and Margin Expansion

The company's operational efficiency showed remarkable improvement with EBITDA reaching ₹1,835 million compared to ₹850 million in the previous year. More notably, the EBITDA margin expanded significantly to 42.4% from 27.5% year-on-year, indicating strong cost management and operational leverage. This substantial margin expansion demonstrates the company's ability to optimize its operations while scaling revenue growth.

FY26 Full Year Performance

For the full fiscal year FY26, the company reported total revenue of ₹13,394 million, up 33.0% from ₹10,069 million in FY25. PAT for FY26 reached ₹3,564 million, a 122.2% increase from ₹1,604 million in the previous year. EBITDA for the year stood at ₹4,804 million with an EBITDA margin of 35.9%, compared to ₹2,321 million and 23.0% respectively in FY25.

Official Board Meeting and Dividend Declaration

In accordance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors at their meeting held on April 30, 2026, recommended a final dividend of ₹2.5 per equity share at the rate of 50% on the face value of ₹5 per share. The dividend is subject to deduction of tax, if any, and requires confirmation by shareholders in the ensuing 19th Annual General Meeting. Company Secretary CS Ekta Kumari Srivastava provided the official intimation to both BSE and NSE exchanges.

Regulatory Compliance and Newspaper Publication

Following the board meeting outcomes, Acutaas Chemicals published its audited financial results for Q4 and FY26 in newspapers on May 1, 2026, in compliance with Regulation 30 & 47 of SEBI regulations. The results were published in Financial Express All India editions (English) and Financial Express Ahmedabad edition (Gujarati) newspapers, ensuring proper disclosure to stakeholders. Company Secretary CS Ekta Kumari Srivastava confirmed the newspaper publication through official intimation to BSE and NSE exchanges.

Auditor Appointments and Material Subsidiary

The Board appointed M/s Chirag Vallabhhai Vekariya & Co., a Cost and Management Accountants firm (Firm Registration No. 001422), as the Cost Auditors for FY 2026-27. Additionally, M/s K. C Mehta & Co. LLP., a Chartered Accountants firm (Firm Registration No. 106237W), was appointed as the Internal Auditors for FY 2026-27. In accordance with the Company's "Policy for Determination of Material Subsidiaries," Indichem INC has been identified as a Material Subsidiary based on the latest audited consolidated financial statements.

Management Outlook

Executive Chairman and Managing Director Mr. Naresh Patel expressed confidence in delivering 25% revenue growth in FY27. The company's strategy focuses on building a diversified chemicals business across three high-growth verticals - Battery Chemicals, Semiconductors, and Pharmaceutical CDMO. The record date, book closure dates, and dividend pay-out date for the final dividend shall be intimated in due course of time.